Literature DB >> 29845554

A case of an elderly female with diffuse hepatic hemangiomatosis complicated with multiple organic dysfunction and Kasabach-Merritt syndrome.

Yoshiaki Shimizu1,2, Takuya Komura3, Takuya Seike3,4, Hitoshi Omura3,4, Tatsuo Kumai3,4, Takashi Kagaya3, Hajime Ohta3, Atsuhiro Kawashima5, Kenichi Harada6, Shuichi Kaneko4, Masashi Unoura3.   

Abstract

Since diffuse hepatic hemangiomatosis (DHH) is an extremely rare disease especially in adults, the etiology and natural course of adult-onset DHH has not been well understood. We report a case of DHH complicated with multiple organic dysfunction and Kasabach-Merritt syndrome (KMS) in an 83-year-old female. She presented with mild abdominal distension and laboratory findings revealed thrombocytopenia and abnormal coagulation, indicating disseminated intravascular coagulation (DIC). Enhanced computed tomography revealed diffuse, hypodense hepatic nodules with delayed enhancement involving the whole liver, and multiple hypodense splenic legions. To obtain a definitive diagnosis, laparoscopic-guided biopsy was performed. Histological findings revealed irregularly dilated non-anastomotic vascular spaces, which were lined with flat endothelial cells without cellular atypia. We diagnosed this as DHH complicated with splenic lesions and KMS. Although the patient was treated with symptomatic treatment, such as anti-coagulation therapy, hemangiomatous lesions, especially in the spleen, progressed rapidly, leading to worsening of DIC. Finally, the patient died of multiple organ failure at 12 months after diagnosis. A postmortem examination demonstrated diffuse hemangiomatosis of not only the liver and spleen, but also the adrenal glands and bone marrow. Despite no malignant histologically, DHH can be fatal if it progresses rapidly within a short period of time.

Entities:  

Keywords:  Adult; Diffuse hepatic hemangiomatosis; Kasabach–Merritt syndrome; Postmortem examination; Vascular endothelial growth factor

Mesh:

Year:  2018        PMID: 29845554     DOI: 10.1007/s12328-018-0871-3

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  20 in total

1.  Clinical challenges and images in GI. Diffuse hepatic hemangiomatosis involving the entire liver.

Authors:  Jin Dong Kim; U Im Chang; Jin Mo Yang
Journal:  Gastroenterology       Date:  2008-05-16       Impact factor: 22.682

Review 2.  Vascular tumors and vascular malformations (new issues).

Authors:  O Enjolras; J B Mulliken
Journal:  Adv Dermatol       Date:  1997

3.  Case reports. Diffuse skeletal and hepatic hemangiomatosis.

Authors:  R C Kane; A B Newman
Journal:  Calif Med       Date:  1973-03

Review 4.  What is changing in indications and treatment of hepatic hemangiomas. A review.

Authors:  Adriana Toro; Ahmed-Emad Mahfouz; Annalisa Ardiri; Michele Malaguarnera; Giulia Malaguarnera; Francesco Loria; Gaetano Bertino; Isidoro Di Carlo
Journal:  Ann Hepatol       Date:  2014 Jul-Aug       Impact factor: 2.400

5.  Imaging of atypical hemangiomas of the liver with pathologic correlation.

Authors:  V Vilgrain; L Boulos; M P Vullierme; A Denys; B Terris; Y Menu
Journal:  Radiographics       Date:  2000 Mar-Apr       Impact factor: 5.333

6.  Association of hepatic hemangiomatosis with giant cavernous hemangioma in the adult population: prevalence, imaging appearance, and relevance.

Authors:  Kartik S Jhaveri; Paraskevi A Vlachou; Maha Guindi; Sandra Fischer; Korosh Khalili; Sean P Cleary; Anoop P Ayyappan
Journal:  AJR Am J Roentgenol       Date:  2011-04       Impact factor: 3.959

7.  Arteriovenous shunting and cholestasis in hepatic hemangiomatosis associated with metoclopramide.

Authors:  G E Feurle
Journal:  Gastroenterology       Date:  1990-07       Impact factor: 22.682

8.  Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.

Authors:  Andrew Mitchell; Leon A Adams; Gerry MacQuillan; Jon Tibballs; Rohan vanden Driesen; Luc Delriviere
Journal:  Liver Transpl       Date:  2008-02       Impact factor: 5.799

9.  Diffuse hepatic hemangiomatosis without extrahepatic involvement in an adult patient.

Authors:  Eun Hui Kim; Soo Youn Park; Yon Kwon Ihn; Seong Su Hwang
Journal:  Korean J Radiol       Date:  2008 Nov-Dec       Impact factor: 3.500

10.  Giant cavernous hemangioma coexistent with diffuse hepatic hemangiomatosis presenting as portal vein thrombosis and hepatic lobar atrophy.

Authors:  Bo Reum Yoo; Hyun Young Han; So Young Choi; Joo Heon Kim
Journal:  Ultrasonography       Date:  2013-11-15
View more
  3 in total

1.  Peritoneal cavernous hemangiomatosis: A case report.

Authors:  Li-Yuan Fu; Hong-Yu Chen; Xiao-Li Diao; Zhen-Jun Wang
Journal:  World J Clin Cases       Date:  2019-02-26       Impact factor: 1.337

2.  Pancreaticoduodenal and choledochal hemangiomatosis with vascular variation in a child: a rare disease with challenge starts from diagnosis-a case report.

Authors:  Daguang Tian; Hong Zhu; Xiaoping Wei
Journal:  World J Surg Oncol       Date:  2022-09-07       Impact factor: 3.253

3.  Adult diffuse hepatic hemangiomatosis.

Authors:  Neha Bhardwaj; Mayur Parkhi; Manish Kumar; Lileswar Kaman; Suvradeep Mitra
Journal:  Autops Case Rep       Date:  2022-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.